...
首页> 外文期刊>Journal of the American College of Nutrition >Interaction between Nonsteroidal Anti-inflammatory Drugs and Low-fat Dietary Intervention on Colorectal Cancer Incidence; the Women's Health Initiative (WHI) Dietary Modification Trial
【24h】

Interaction between Nonsteroidal Anti-inflammatory Drugs and Low-fat Dietary Intervention on Colorectal Cancer Incidence; the Women's Health Initiative (WHI) Dietary Modification Trial

机译:非甾体抗炎药与低脂肪膳食干预对结直肠癌发病的相互作用; 妇女的健康倡议(WHI)膳食修改试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The Women's Health Initiative (WHI) Dietary Modification (DM) trial did not show that reductions in dietary fat accompanied by increases in vegetable and fruit consumption decrease the incidence of colorectal cancer. Secondary analyses suggested that aspirin use may modify the intervention effects of DM on colorectal cancer development, although a recent reanalysis including the postintervention period confirmed no main effect of the intervention on reducing colorectal cancer incidenceMethods: We analyzed data from 48,834 postmenopausal women who were randomized into the low-fat DM (N = 19,540) or comparison (N = 29,294) group for an average 8.1years and followed for an additional 9.4years through August 31, 2014. Exposure to specific class(es) or strength(s) of nonsteroidal anti-inflammatory drugs (NSAIDs) was modeled at baseline and as time-dependent use through the 9-year clinic visit. A Cox proportional hazard model was employed to assess the association of the DM, medication use, and their interaction with colorectal cancer events.Results: A total of 906 incident cases of colorectal cancer were identified during the intervention and postintervention periods. By both exposure models, we found that colorectal cancer incidence was not different in the DM from the comparison group among any type of NSAID users. None of the interactions with any category of NSAID use was statistically significant; however there was most modest evidence for an interaction (p = 0.07) with aspirin use at baseline (hazard ratio [HR] = 0.81, 95% confidence interval [CI], 0.60-1.11 for users; HR = 1.12, 95% CI, 0.97-1.30 for nonusers). Strength and duration of aspirin use at baseline did not alter the associations.Conclusion: Extended follow-up of women in the WHI DM trial did not confirm combined protective effects of aspirin and low-fat diet on colorectal cancer risk among the postmenopausal women.
机译:背景:妇女的健康倡议(WHI)饮食改性(DM)试验未显示伴随蔬菜和果实消耗增加的膳食脂肪的减少降低了结直肠癌的发病率。二次分析表明,阿司匹林可以使用DM对结直肠癌发育的干预效果,尽管最近在包括临时期间的再分析证实干预关于减少结肠直肠癌侵袭的主要效果:我们分析了从随机分配的48,834名绝经后妇女的数据低脂肪DM(n = 19,540)或比较(n = 29,294)组平均为8岁,并在2014年8月31日之前举行了额外的9.4年。抗炎药(NSAIDs)在基线上进行建模,并通过9年诊所访问的时间使用。使用Cox比例危害模型来评估DM,药物用途及其与结直肠癌事件的相互作用的关联。结果:在干预和初期预防期间,共鉴定了906例结直肠癌。通过两个曝光模型,我们发现,在任何类型的NSAID用户之间,DM中的结肠直肠癌发病率在DM中没有不同。没有任何与任何类别的NSAID使用的相互作用是统计学意义的;然而,在基线上使用阿司匹林(P = 0.07)的相互作用(p = 0.07)最适时(危险比[HR] = 0.81,95%置信区间[CI],0.60-1.11为用户; HR = 1.12,95%CI,非用户0.97-1.30)。 Aspirin在基线中使用的强度和持续时间没有改变关联。结论:WHI DM试验中的妇女的延长随访未确认阿司匹林和低脂饮食在绝经后妇女中的结肠直肠癌风险的组合保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号